Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy

Conclusion: Curative RT plus rIL-2 immunotherapy provided an efficient, effective means of treating angiosarcoma of the scalp. Arterial or intratumoral administration combined with systemic administration of rIL-2 may prolong survival. Additional studies with detailed treatment protocols are recommended.